Evidence map›Paper›PMID 39770563›Full record

ReviewPharmaceuticals (Basel, Switzerland)2024

Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.

Katarzyna Jóźwik-Plebanek, Marek Saracyn, Maciej Kołodziej, Olga Kamińska, Adam Daniel Durma, Weronika Mądra, Katarzyna Agnieszka Gniadek-Olejniczak, Marek Dedecjus, Jakub Kucharz, Rafał Stec and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Katarzyna Jóźwik-PlebanekDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0002-6756-5415
Marek SaracynDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Maciej KołodziejDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0003-1943-264X
Olga KamińskaDepartment of Nuclear Medicine, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Adam Daniel DurmaDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0001-7103-2577
Weronika MądraDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0009-0001-1050-2704
Katarzyna Agnieszka Gniadek-OlejniczakNeurorehabilitation Clinic, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.
Marek DedecjusDepartment of Oncological Endocrinology and Nuclear Medicine, Maria Skłodowska-Curie National Institute of Oncology, 02-781 Warsaw, Poland.ORCID 0000-0003-3485-8219
Jakub KucharzDepartment of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Rafał StecDepartment of Oncology, Warsaw Medical University, 02-097 Warsaw, Poland.ORCID 0000-0002-3291-6422
Grzegorz KamińskiDepartment of Endocrinology and Radioisotope Therapy, Military Institute of Medicine-National Research Institute, 04-141 Warsaw, Poland.ORCID 0000-0002-2357-0634

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

positron emission tomography/computed tomographyprostate-specific membrane antigenrenal cell carcinoma

Identifiers

PMID39770563
PMCPMC11678666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.